InMed Pharmaceuticals
NASDAQ: INM
$1.59
+0.15
(+10.42%)
as on
InMed Pharmaceuticals Stock Performance
as on August 20, 2026 at 2:16 pm IST
Day's Low
Day's High
$1.51$1.63
5.03%
Downside
2.52%
Upside
52 Week's Low
52 Week's High
$0.58$2.5063.84%
Downside
57.23%
Upside
InMed Pharmaceuticals share price movements today
- Previous Close
- $1.44
- Open
- $1.54
- Volume
- 251.8K
- Market Cap
- $7.8M
- Day's Low - High
- $1.51 - $1.63
- 52 Week Low - High
- $0.58 - $2.50
InMed Pharmaceuticals Historical Returns
- 1 Month Return
- -3.29 %
- 3 Month Return
- + 129.65 %
- 1 Year Return
- -36.64 %
- 3 Year Return
- -91.65 %
- 5 Year Return
- -99.87 %
InMed Pharmaceuticals Stock Fundamentals & Key Indicators
Check InMed Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.8M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-7.8M
Revenue (TTM)
4.9M
Profit Margin
-172.17%
Return On Equity TTM
-112.65%
InMed Pharmaceuticals stock Key Stats
Compare market cap, revenue, PE, and other key metrics of InMed Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| $7.8M | -99.87% | NA | -172.17% | NA |
Stock Returns calculator for InMed Pharmaceuticals Stock including INR - Dollar returns
The InMed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
InMed Pharmaceuticals investment value today
Current value as on today
₹75,361
Returns
Returns from InMed Pharmaceuticals Stock
Dollar Impact
₹6,827 (+6.83%)
Analyst Recommendation on InMed Pharmaceuticals Stock
Based on 8 analysts
0.00%
Buy
37.50%
Hold
62.50%
Sell
Based on 8 analysts, 62.5% of analysts recommend a 'SELL' rating for InMed Pharmaceuticals. Average target price of $20
InMed Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on InMed Pharmaceuticals.
What analysts predicted
92.05%UPSIDE
Target Price
$20
Current Price
$1.59
Analyzed by
8 Analysts
Target
$20.00
InMed Pharmaceuticals target price $20, a slight upside of 92.05% compared to current price of $1.59. According to 8 analysts rating.
Indian Investors' Interest in InMed Pharmaceuticals Stock
Search interest for InMed Pharmaceuticals Stock has increased by 833% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:833% versus previous 30 day period
InMed Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
InMed Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
InMed Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
InMed Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
InMed Pharmaceuticals News & Key Events
Today's Timeline - 22 July
Thu, 00:16 AM
-Mentari Therapeutics raises $200 million before merging with InMed Pharmaceuticals, enhancing its migraine treatment pipeline.
Insights on InMed Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, INM stock has moved up by 11.2%
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 68.54% to 69.47% in Mar 2026 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.12M → 659.84M (in $), with an average increase of 50.2% per quarter
NO EFFECTAgainst Peers
In the last 1 year, United Therapeutics Corporation Common Stock has given 72.7% return, outperforming this stock by 101.1%
- NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation Common Stock has given 130.3% return, outperforming this stock by 221.3%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 26.20% to 26.13% in Mar 2026 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 5.26% to 4.40% in Mar 2026 quarter
- NEGATIVE IMPACT
Price Dip
In the last 6 months, INM stock has moved down by -15.4%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -1.72M → -2.96M (in $), with an average decrease of 33.9% per quarter
About InMed Pharmaceuticals
| Organisation | InMed Pharmaceuticals |
| Headquarters | 885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8 |
| Industry | Drug Manufacturers - Specialty & Generic |
| CEO | Mr. Eric A. Adams B.S. Chem., M.I.B. |
| E-voting on shares | Click here to vote |
Key Management of InMed Pharmaceuticals
Name | Title |
|---|---|
Ms. N. Netta Jagpal | CFO & Corporate Secretary |
Mr. Michael Woudenberg P.Eng. | Chief Operating Officer |
Dr. Eric Chih-Hsien Hsu Ph.D. | Senior Vice President of Preclinical Research & Development |
Dr. Sazzad Hossain M.Sc., Ph.D. | Co-Founder |
Mr. Colin Clancy | VP of Investor Relations & Corporate Communications |
Mr. Jerry P. Griffin | Vice President of Sales & Marketing |
Dr. Shane A. Johnson Ph.D. | Senior VP & GM of BayMedica |
Mr. Eric A. Adams B.S. Chem., M.I.B. | President, CEO & Director |
FAQs
What is InMed Pharmaceuticals share price today?
InMed Pharmaceuticals share price today is $1.59 as on at the close of the market. InMed Pharmaceuticals share today touched a day high of $1.63 and a low of $1.51.
What is the 52 week high and 52 week low for InMed Pharmaceuticals share?
InMed Pharmaceuticals share touched a 52 week high of $2.50 on and a 52 week low of $0.58 on . InMed Pharmaceuticals stock price today i.e. is closed at $1.59,which is 36.40% down from its 52 week high and 176.52% up from its 52 week low.
What is InMed Pharmaceuticals's market capitalisation today?
InMed Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in InMed Pharmaceuticals Stock (INM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for InMed Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in InMed Pharmaceuticals Shares that will get you 0.9434 shares as per InMed Pharmaceuticals share price of $1.59 per share as on August 20, 2026 at 8:46 am IST.
What is the minimum amount required to buy InMed Pharmaceuticals Stock (INM) from India?
Indian investors can start investing in InMed Pharmaceuticals (INM) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in InMed Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on InMed Pharmaceuticals share’s latest price of $1.59 as on August 20, 2026 at 8:46 am IST, you will get 6.2893 shares of InMed Pharmaceuticals. Learn more about
fractional shares .
What are the returns that InMed Pharmaceuticals has given to Indian investors in the last 5 years?
InMed Pharmaceuticals stock has given -99.87% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?